General MedicationsORALGeneric

SOMA COMPOUND

ASPIRIN; CARISOPRODOL

Standard Dose

325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview SOMA COMPOUND is listed in Drugs@FDA under application 012365 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; CARISOPRODOL Form and strength TABLET;ORAL - 325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDA PHARMS Submission history Latest submission status date: 2013-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOMA COMPOUND is listed in Drugs@FDA under application 012365 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; CARISOPRODOL Form and strength TABLET;ORAL - 325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDA PHARMS Submission history Latest submission status date: 2013-01-31 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.